Masterclass series in peripheral arterial disease

Uusitupa M , Niskanen L , Siitonen O , Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to gender, risk factors, insulin level and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic individuals. Circulation 1990; 82:27-36.

Fowkes FG. Epidemiological research on peripheral vascular disease. J Clin Epidemiol 2001; 54: 863-868.

Da Silva A , Desgranges P , Holdsworth J et al. The management and outcome of critical limb ischaemia in diabetic patients: results of a national survey. Audit committee of the vascular surgical society of Great Britain and Ireland. Diabet Med 1996; 13:726-728.

Jude EB , Oyibo SO , Chalmers N , Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24: 1433-1437.

Mehler P , Jeffers B , Estacio R , Schrier R. Associations of hypertension and complications in NIDDM. Am J Hypertens 1997; 10:152-161.

Beks P , Mackaay A , de Neeling J , de Vries H , Bouter L , Heine M. Peripheral aterial disease in relation to glycaemic level in an elderly caucasian population: the Hoorn study. Diabetologia 1995; 38: 86-96.

Forrest KY , Becker DJ , Kuller LH , Wolfson SK , Orchard TJ. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 2000; 148: 159-169.

Adler A , Stevens R , Neil A , Stratton I , Boulton A , Holman R. UKPDS 59: hyperglycaemia and other potentially modifiable risk factors for peripheral arterial disease in type 2 diabetes. Diabetes Care 2002; 25: 894-899.

Price J , Lee A , Fowkes F. Hyperinsulinaemia: a risk factor for peripheral arterial disease in the non-diabetic population. J Cardiovasc Risk 1996; 3: 501-505.

Matsumoto K , Miyake S , Yano M et al. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM. Diabetes Care 1997; 20: 1738-1743.

Baynes JW , Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.

Schmidt A , Yan S , Wautier J , Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999; 84: 489-497.

Idris I , Gray S , Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001; 44:659-673.

Ishii H , Jirousek MR , Koya D etal. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC-b inhibitor. Science 1996; 272:728-731.

Beckman JA , Goldfine AB , Gordon MB , Garrett LA , Creager MA. Inhibition of protein kinase C-b prevents impaired endothelium-dependent vasodilation caused by hyperglycaemia. Circ Res 2002; 90: 107-111.

Inoguchi T , Li P , Umeda F et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells. Diabetes 2000; 49:1939-1945.

Creager MA , Luscher TF. Diabetes and vascular disease. Pathophysiology, clinical consequences and medical therapy: Part 1. Circulation 2003; 108:1527-1532.

Kuboki K , Jiang ZY , Takahara N et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000; 101:676-681.

Laakso M , Edelman SV , Brechtel G et al. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism of insulin resistance. J Clin Invest 1990; 85: 1844-1852.

Mather K , Laakso M , Edelman S et al. Evidence for physiological coupling of insulin-mediated glucose metabolism and limb blood flow. Am J Physiol Endocrinol Metab 2000; 279: E1264-E1270.

Mather KJ , Verma S , Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 2001; 37: 1344-1350.

DCCT Study Group . Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995; 75: 894-903.

UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.

UK Prospective Diabetes Study (UKPDS) Group . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.

MacGregor A , Price J , Hau C , Lee A , Carson M , Fowkes F. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study. Diabetes Care 1999; 22: 453-458.

Adler A , Stratton I , Neil A et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 2000; 321: 412-419.

Mehler PS , Coll JR , Estacio R , Esler A , Schrier RW , Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003; 107:753-756.

Collins R , Armitage J , Parish S , Sleight P , Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.

McKenna M , Wolfson S , Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87: 119-128.

Taniyama Y , Morishita R , Hiraoka K , Aoki M , Nakagami H. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischaemia model. Circulation 2001; 104: 2344-2350.

Rivard A , Silver M , Chen D , Kearney M , Magner M , Annex B. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154:355-363.

Belcaro G , Nicolaides AN , Griffin M , De Sanctis MT , Cesarone MR , Incandela L. Intermittent claudication in diabetics: treatment with exercise and pentoxifylline a 6-month, controlled, randomized trial. Angiology 2002; 53 (suppl 1): S39-S43.

Hittel N , Donnelly R. Treating peripheral arterial disease in patients with diabetes. Diabetes Obes Metab 2002; 4 (suppl 2): S26-S31.